Company Filing History:
7 out of 968 
6 out of 87 
2 out of 170 
Years Active: 2007-2025
Title: **Innovative Contributions of Jason McClure**
Introduction
Jason McClure, an esteemed inventor based in San Diego, CA, has made significant strides in the field of medical diagnostics. With an impressive portfolio of 13 patents, he has contributed to innovations that enhance disease detection and improve healthcare outcomes.
Latest Patents
Among his latest innovations is an **immunoassay test device featuring two fluid flow paths** for detecting and differentiating multiple analytes. This device efficiently determines the presence or absence of infections caused by infectious agents. It comprises a sample receiving zone that distributes the sample along two distinct fluid flow paths leading to separate label zones. Each path includes test lines designed to capture a mobile detectable species, providing crucial indicators of infectious agents. Additionally, this device incorporates a reference line within one of the fluid flow paths, further enhancing its detection capabilities. Another notable patent involves an **extraction reagent** for detecting Group A through an enzymatic extraction agent, which includes methods and kits for analyzing biological samples effectively.
Career Highlights
Jason has held pivotal roles in leading companies such as **Dexcom, Inc.** and **Quidel Corporation**, where his expertise in diagnostics and innovation thrived. His work has had a transformative impact on how infections are detected and managed in clinical settings.
Collaborations
Throughout his career, Jason has collaborated with notable colleagues, including **Mark Allan Tapsak** and **Rathbun K. Rhodes**. These partnerships have fostered innovative approaches and enhanced the quality of research and development in medical diagnostics.
Conclusion
With his extensive patent portfolio and commitment to innovation, Jason McClure exemplifies the spirit of invention in the medical field. His contributions not only further our understanding of infectious diseases but also pave the way for advancements in diagnostic technology that can improve patient care and outcomes.